drugset / Trial / NCT00588393

FolateScan in Autoimmune Disease

NCT00588393

Phase 2 Completed 75 enrolled Mayo Clinic Endocyte · collab
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

This study will gather information on the safety of FolateScan and the ability of FolateScan to detect inflammation in the joints and other organs in people with arthritis (rheumatoid arthritis and osteoarthritis), systemic lupus erythematosus, multiple sclerosis, interstitial pneumonitis, Crohn's disease as well as in healthy persons without these conditions.

Timeline

Start
2006-09
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject EC20 Diagnostic / imaging agent 0.1 mg